Hemispherx Biopharma Issues Letter to Stockholders
Business Update and Apple iOS Stocks Advisory OCALA, Fla., Dec. 12, 2018 (GLOBE NEWSWIRE) — Hemispherx Biopharma, Inc. (NYSE American: […]
Zosano Receives Conditional FDA Acceptance of Proposed Brand Name Qtrypta™ for M207
FREMONT, Calif., Dec. 12, 2018 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company, today […]
Preclinical Data on Vaccinex, Inc. Anti-SEMA4D Monoclonal Antibody in Combination with Checkpoint Inhibitors Published in Cancer Immunology Research
ROCHESTER, N.Y., Dec. 12, 2018 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company engaged in the discovery and […]
Taoping Alliance Membership Reaches 99 Companies
SHENZHEN, China, Dec. 12, 2018 (GLOBE NEWSWIRE) — Taoping Inc. (NASDAQ: TAOP), a leading provider of internet-based advertisement distribution and […]
Amyris Receives GRAS Notification from FDA for its New, Sugarcane-Derived, Zero Calorie Sweetener
EMERYVILLE, Calif., Dec. 12, 2018 (GLOBE NEWSWIRE) — Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable […]
MeiraGTx Announces Publication of New Research Identifying Underlying Mechanism of Functional Improvement Seen with AAV-GAD Gene Therapy in Parkinson’s Disease
Findings Published in Science Translational Medicine Show AAV-GAD Exerts Clinical Benefits by Inducing the Formation of New Brain Pathways Results […]
XBiotech’s Results from Phase 2 Atopic Dermatitis Study Suggest New Drug to Treat Skin Disease
Bermekimab Therapy Rapidly and Significantly Reduces Disease AUSTIN, Texas, Dec. 12, 2018 (GLOBE NEWSWIRE) — XBiotech (NASDAQ: XBIT) announced today […]
Orgenesis Announces Collaboration with Ben-Gurion University to Research and Develop Dissolvable Carriers for Cell Culturing
GERMANTOWN, Md. and BEER-SHEVA, Israel, Dec. 12, 2018 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ: ORGS), a developer of advanced cell […]
Adaptimmune Announces that Gwen Binder will leave in January 2019
PHILADELPHIA and OXFORD, United Kingdom, Dec. 12, 2018 (GLOBE NEWSWIRE) — Adaptimmune (Nasdaq: ADAP), a leader in T-cell therapy to […]
Green Plains and Optimal Fish Food Announce Formation of Aquafeed Joint Venture
Optimal Aquafeed created to address fast growing Aquaculture feed markets OMAHA, Neb. and BROOKINGS, S.D., Dec. 12, 2018 (GLOBE NEWSWIRE) […]
